» Articles » PMID: 39062718

Using Genetics to Investigate Relationships Between Phenotypes: Application to Endometrial Cancer

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2024 Jul 27
PMID 39062718
Authors
Affiliations
Soon will be listed here.
Abstract

Genome-wide association studies (GWAS) have accelerated the exploration of genotype-phenotype associations, facilitating the discovery of replicable genetic markers associated with specific traits or complex diseases. This narrative review explores the statistical methodologies developed using GWAS data to investigate relationships between various phenotypes, focusing on endometrial cancer, the most prevalent gynecological malignancy in developed nations. Advancements in analytical techniques such as genetic correlation, colocalization, cross-trait locus identification, and causal inference analyses have enabled deeper exploration of associations between different phenotypes, enhancing statistical power to uncover novel genetic risk regions. These analyses have unveiled shared genetic associations between endometrial cancer and many phenotypes, enabling identification of novel endometrial cancer risk loci and furthering our understanding of risk factors and biological processes underlying this disease. The current status of research in endometrial cancer is robust; however, this review demonstrates that further opportunities exist in statistical genetics that hold promise for advancing the understanding of endometrial cancer and other complex diseases.

Citing Articles

Genetic variation perspective reveals potential drug targets for subtypes of endometrial cancer.

Zhu J, Zhang T, Jiang J, Yang M, Xia N, Chen Y Sci Rep. 2024; 14(1):28180.

PMID: 39548148 PMC: 11568156. DOI: 10.1038/s41598-024-78689-5.

References
1.
Glubb D, Thompson D, Aben K, Alsulimani A, Amant F, Annibali D . Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers. Cancer Epidemiol Biomarkers Prev. 2020; 30(1):217-228. DOI: 10.1158/1055-9965.EPI-20-0739. View

2.
Crosbie E, Kitson S, McAlpine J, Mukhopadhyay A, Powell M, Singh N . Endometrial cancer. Lancet. 2022; 399(10333):1412-1428. DOI: 10.1016/S0140-6736(22)00323-3. View

3.
Bowden J, Del Greco M F, Minelli C, Davey Smith G, Sheehan N, Thompson J . A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med. 2017; 36(11):1783-1802. PMC: 5434863. DOI: 10.1002/sim.7221. View

4.
Lee S, van der Werf J . MTG2: an efficient algorithm for multivariate linear mixed model analysis based on genomic information. Bioinformatics. 2016; 32(9):1420-2. PMC: 4848406. DOI: 10.1093/bioinformatics/btw012. View

5.
Setiawan V, Yang H, Pike M, McCann S, Yu H, Xiang Y . Type I and II endometrial cancers: have they different risk factors?. J Clin Oncol. 2013; 31(20):2607-18. PMC: 3699726. DOI: 10.1200/JCO.2012.48.2596. View